Skip to main content
. 2023 Oct 17;10:1195026. doi: 10.3389/fmed.2023.1195026

Figure 3.

Figure 3

(A) Breast tumor size graph of patient ID#1. It showed a significant reduction in the tumors’ size in the PECT site, while PECT did not affect the 3 O’clock mass as a benign tumor. (B) The clinical parameters measured in patient ID#1: Right Wrist Circumference (RWC), Right Elbow Circumference (REC), Right Arm Circumference (RAC), Left Wrist Circumference (LWC), Left Elbow Circumference (LEC), and Left Arm Circumference (LAC). They improved with PECT. (C) Serum electrolytes of patient ID#1 showed no significant changes during PECT. (D) Ki67 expression showed a substantial reduction of proliferation factor in the exposed site before and after the PECT. (E) Breast Tumors sizes of patient ID#2. The breast tumors showed a significant size reduction. (F) Serum electrolytes of patient ID#2 during PECT. (G) Breast tumor sizes of patient ID#3 were demonstrated from 30 days before PECT and during PECT. Tumor in the far zone of the breast vanished completely, and the other ones showed size reduction. (H) Lymph node sizes of patient ID#3. The sizes decreased significantly during PECT. Although, they all had shown an upward trend before PECT. (I) Serum electrolytes of patient ID#3 during PECT showed no significant changes. The reference intervals of serum biomarkers and blood biochemistry factors are presented in Supplementary Table 3.